Breaking News Instant updates and real-time market news.

CRTO

Criteo

$21.97

-3.48 (-13.67%)

, FB

Facebook

$164.48

1.96 (1.21%)

10:38
09/07/18
09/07
10:38
09/07/18
10:38

Criteo lost Facebook Marketing Partner status, says Goldman Sachs

Recent French press reports, which have been verified by the company, confirm that Facebook (FB) decertified Criteo as a Facebook Marketing Partner on July 1, meaning Criteo is no longer referenced as a Facebook preferred marketing partner and will not have access to beta testing new features, Goldman Sachs analyst Heath Terry told investors in a note sent before the open. While he expects the financial impact to be limited in the near-term, noting that Facebook only represented 4% of Criteo revenue ex-TAC in Q2, Terry sees this as a further sign of tightening standards among advertisers and publishers. He keeps a Neutral rating on Criteo shares and lowered his 2018-2020 revenue ex-TAC estimates by 2%, on average, to reflect potential pressure to net revenue from Facebook.

CRTO

Criteo

$21.97

-3.48 (-13.67%)

FB

Facebook

$164.48

1.96 (1.21%)

  • 11

    Sep

  • 12

    Sep

  • 18

    Sep

  • 28

    Oct

CRTO Criteo
$21.97

-3.48 (-13.67%)

08/02/18
JPMS
08/02/18
DOWNGRADE
Target $26
JPMS
Neutral
Criteo downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Douglas Anmuth downgraded Criteo to Neutral and lowered his price target for the shares to $26 from $38. While the company's strategic partner approach is right for the long term, it reduces near-term estimates and adds uncertainty, Anmuth tells investors in a research note following Criteo's Q2 results.
08/02/18
DBAB
08/02/18
NO CHANGE
Target $38
DBAB
Buy
Criteo price target lowered to $38 from $50 at Deutsche Bank
Deutsche Bank analyst Lloyd Walmsley lowered his price target for $38 following the company's Q2 results. The analyst, however, keeps a Buy rating on the shares despite a "disappointing outlook and concerning trends." The analyst believes Criteo is "taking its medicine - operationally and from a guidance perspective," and he likes the risk/reward at current share levels.
08/02/18
RHCO
08/02/18
NO CHANGE
Target $33
RHCO
Buy
Criteo price target lowered to $33 from $39 at SunTrust
SunTrust analyst Matthew Thornton lowered his price target on Criteo to $33 after the company's "out of left field" internal issues resulted in the reduction of its FY revenue growth outlook. The analyst notes that the steps by the returning CEO to reposition the company's products and salesforce is weighing on its credibility. Thornton also kept his Buy rating on Criteo on valuation, growing cash, and the management's expectations of high-single-digit sales growth next year.
08/02/18
KEYB
08/02/18
NO CHANGE
Target $42
KEYB
Overweight
Criteo price target lowered to $42 from $50 at KeyBanc
KeyBanc analyst Andy Hargreaves lowered his price target for Criteo to $42 from $50 following quarterly results. The analyst reiterates an Overweight rating on the shares and recommends buying the stock as he continues to believe accelerating growth can drive improved investor sentiment through 2019.
FB Facebook
$164.48

1.96 (1.21%)

08/30/18
MKMP
08/30/18
NO CHANGE
Target $43
MKMP
Buy
Twitter DAUs as 'monetizable' as Facebook's, says MKM Partners
MKM Partners analyst Rob Sanderson keeps his Buy rating and $43 price target on Twitter (TWTR), saying the latest quarter was a "healthy reset" as the company still offers a "great and differentiated content story". The analyst also believes that Twitter's Daily Active User count is "at least" as monetizable as that of Facebook (FB) and possibly more so over time, even though the company is currently spending its capital on network health. Sanderson adds that he still believes in the "potential for a mass-market Twitter one day", with the continued development of AI technology serving as a possible user experience break-through opportunity.
09/04/18
MOFT
09/04/18
DOWNGRADE
MOFT
Neutral
Facebook downgraded to Neutral from Buy at MoffettNathanson
09/04/18
09/04/18
DOWNGRADE
Target $175

Neutral
Facebook downgraded to Neutral with $175 price target at MoffettNathanson
As previously reported, MoffettNathanson analyst Michael Nathanson downgraded Facebook to Neutral from Buy as he believes the shift in engagement and monetization from News Feed to Stories will be a headwind to revenue growth. He also expects 2019 operating income growth to slow down to a low teens percentage, which should limit further multiple expansion. The company is transitioning from a "frictionless model," in which both user-generated content and advertising were largely unsupervised by humans, to one with higher investments and security, Nathanson tells investors. Additionally, Facebook is increasingly under scrutiny from politicians and regulators globally, which should make it become more aggressive on spending to "show contrition," he contends. Nathanson cut his price target on Facebook shares to $175 from $200.
09/04/18
09/04/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Facebook (FB) downgraded to Neutral from Buy at MoffettNathanson with analyst Michael Nathanson saying he believes the shift in engagement and monetization from News Feed to Stories will be a headwind to revenue growth. 2. Verizon (VZ) downgraded to Equal Weight from Overweight at Barclays and to Neutral from Buy at MoffettNathanson. 3. Dollar Tree (DLTR) downgraded to Outperform from Top Pick at RBC Capital with analyst Scot Ciccarelli citing continued struggles at its Family Dollar business of 3 consecutive quarters of disappointing results, weighing on the company's profitability. 4. Seagate (STX) downgraded to Underperform from In Line at Evercore ISI with analyst C.J. Muse citing peaking margins and HDD secular headwinds. 5. Signet Jewelers (SIG) downgraded to Sell from Neutral at Citi with analyst Paul Lejuez saying while the company's Q2 sales were better than expected with overall comps of up 1.7%, the underlying fundamentals do not suggest that business is healthy. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

FITB

Fifth Third

$30.24

0.365 (1.22%)

, CSCO

Cisco

$43.83

0.29 (0.67%)

18:37
12/06/19
12/06
18:37
12/06/19
18:37
Hot Stocks
Fifth Third issues statement on temporary network outage »

Fifth Third Bank (FITB)…

FITB

Fifth Third

$30.24

0.365 (1.22%)

CSCO

Cisco

$43.83

0.29 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

  • 12

    Dec

  • 08

    Jan

  • 12

    Feb

STML

Stemline

$10.33

0.5 (5.09%)

, PFE

Pfizer

$38.29

0.26 (0.68%)

18:33
12/06/19
12/06
18:33
12/06/19
18:33
Hot Stocks
Stemline names Robert Francomano as Chief Commercial Officer »

Most recently, Francomano…

STML

Stemline

$10.33

0.5 (5.09%)

PFE

Pfizer

$38.29

0.26 (0.68%)

GSK

GlaxoSmithKline

$45.51

0.29 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Dec

  • 11

    Dec

GOL

Gol Linhas

$17.39

1.07 (6.56%)

18:31
12/06/19
12/06
18:31
12/06/19
18:31
Hot Stocks
Gol Linhas announces preliminary traffic figures for November »

GOL's domestic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAVB

Navidea

$0.97

0.07 (7.78%)

18:25
12/06/19
12/06
18:25
12/06/19
18:25
Syndicate
Navidea announces $1.9M private placement »

Navidea announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFC

Ellington Financial

$18.22

0.09 (0.50%)

18:23
12/06/19
12/06
18:23
12/06/19
18:23
Hot Stocks
Ellington Financial reports estimated book value per share $18.51 on November 30 »

This estimate includes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOOT

Boot Barn

$41.93

0.81 (1.97%)

18:22
12/06/19
12/06
18:22
12/06/19
18:22
Hot Stocks
Boot Barn CEO: More than 80% of our business is in the store »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERIC

Ericsson

$9.24

0.1 (1.09%)

18:18
12/06/19
12/06
18:18
12/06/19
18:18
Hot Stocks
Ericsson to pay over $1B to settle FCPA case »

Ericsson has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

GLD

SPDR Gold Shares

$137.59

-1.42 (-1.02%)

17:55
12/06/19
12/06
17:55
12/06/19
17:55
Hot Stocks
SPDR Gold Shares holdings fall to 886.23MT from 888.57MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PICO

PICO Holdings

$10.81

0.31 (2.95%)

17:45
12/06/19
12/06
17:45
12/06/19
17:45
Hot Stocks
PICO Holdings sells long-term storage credits for $8.7M in Arizona »

PICO Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QHC

Quorum Health

$0.95

0.0522 (5.81%)

17:31
12/06/19
12/06
17:31
12/06/19
17:31
Hot Stocks
Quorum Health receives NYSE continued listing standard notice »

Quorum Health Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPRT

Support.com

$1.94

0.01 (0.52%)

17:30
12/06/19
12/06
17:30
12/06/19
17:30
Hot Stocks
Breaking Hot Stocks news story on Support.com »

Support.com trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXRX

Baudax Bio

$6.69

0.34 (5.35%)

17:29
12/06/19
12/06
17:29
12/06/19
17:29
Syndicate
Breaking Syndicate news story on Baudax Bio »

Baudax Bio files $125M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

LMT

Lockheed Martin

$387.10

1.175 (0.30%)

17:25
12/06/19
12/06
17:25
12/06/19
17:25
Hot Stocks
Lockheed Martin awarded $153.39M Navy contract modification »

Lockheed Martin was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENV

Envestnet

$71.72

1.27 (1.80%)

17:23
12/06/19
12/06
17:23
12/06/19
17:23
Syndicate
Breaking Syndicate news story on Envestnet »

Envestnet files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOC

Northrop Grumman

$344.79

0.4 (0.12%)

17:20
12/06/19
12/06
17:20
12/06/19
17:20
Hot Stocks
Northrop Grumman awarded $189M Navy contract modification »

Northrop Grumman was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPRT

Support.com

$1.94

0.01 (0.52%)

17:03
12/06/19
12/06
17:03
12/06/19
17:03
Hot Stocks
Support.com announces special distribution of $1.00 per share »

The record date for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPRT

Support.com

$1.94

0.01 (0.52%)

17:01
12/06/19
12/06
17:01
12/06/19
17:01
Hot Stocks
Breaking Hot Stocks news story on Support.com »

Support.com trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RZLT

Rezolute

$0.00

(0.00%)

17:00
12/06/19
12/06
17:00
12/06/19
17:00
Syndicate
Breaking Syndicate news story on Rezolute »

Rezolute files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,750.79

10.2 (0.59%)

16:58
12/06/19
12/06
16:58
12/06/19
16:58
Periodicals
U.S. mulls putting Amazon foreign sites on 'Notorious Markets' list, WSJ says »

The Trump administration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGTA

Magenta Therapeutics

$13.29

0.3 (2.31%)

16:55
12/06/19
12/06
16:55
12/06/19
16:55
Conference/Events
Magenta Therapeutics to hold an investor and analyst event »

Investor and Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

IMH

IMPAC Mortgage

$5.63

-0.01 (-0.18%)

16:54
12/06/19
12/06
16:54
12/06/19
16:54
Syndicate
Breaking Syndicate news story on IMPAC Mortgage »

IMPAC Mortgage files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALEC

Alector

$19.74

0.33 (1.70%)

16:32
12/06/19
12/06
16:32
12/06/19
16:32
Hot Stocks
Alector reports Phase 1 safety, biomaker data on AL002 »

Alector reported safety…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATAX

America First Multifamily Investors

$7.58

0.125 (1.68%)

16:31
12/06/19
12/06
16:31
12/06/19
16:31
Hot Stocks
America First Multifamily Investors CFO Craig Allen to retire »

On December 2,Craig Allen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
12/06/19
12/06
16:30
12/06/19
16:30
Options
Preliminary option volume of 20.4M today »

Preliminary option volume…

PNM

PNM Resources

$48.77

-0.06 (-0.12%)

16:29
12/06/19
12/06
16:29
12/06/19
16:29
Hot Stocks
PNM Resources raises quarterly dividend 6% to 30.75c per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.